Latest Exploration News

Forrestania Resources Limited has initiated an all-scrip off-market takeover offer for Kula Gold Limited, aiming to consolidate gold exploration assets across Western Australia. The offer, valued up to $58.7 million, comes with unanimous backing from Kula's board.

A former director of Emu NL has lodged a formal application with the Takeovers Panel, contesting the legitimacy of a recent $1.4 million institutional placement and alleging undisclosed attempts to influence board control.

Forrestania Resources has updated the opening date of its Share Purchase Plan to 9 December 2025, aligning it with key corporate events and offering shareholders a chance to buy shares at $0.175 each alongside new option incentives.

Venus Metals Corporation has acknowledged an on-market takeover bid from QGold at $0.17 per share, matching the last closing price. The Venus Board advises shareholders to take no immediate action as they assess the offer’s value against the company’s substantial asset base.

Race Oncology Limited has secured shareholder approval for a replacement Constitution at its 2025 Annual General Meeting, updating its corporate governance framework to align with current regulatory standards.

Chrysos Corporation reports nearly one million monthly PhotonAssay samples and reiterates strong FY26 revenue guidance, while unveiling next-gen assay technologies and global expansion plans.

Rox Resources (ASX – RXL) has delivered a comprehensive update on its Youanmi Gold Project, highlighting a compelling Definitive Feasibility Study and significant funding progress that set the stage for production in 2026.

Skylark Minerals has acquired a high-grade gold portfolio in Côte d'Ivoire, including a flagship project with a 364,600-ounce inferred resource, marking a significant step in its West African growth strategy. The company is fully funded to accelerate exploration in early 2026, targeting resource expansion and new discoveries.

Genmin Limited has successfully completed the first tranche of its capital raising, issuing over 131 million shares to fund its flagship Baniaka iron ore project in Gabon, targeting production by late 2026.

Pro Medicus Ltd has delivered a record-breaking FY2025 with revenue soaring nearly 32% and net profit up 39%, driven by landmark contracts and a robust growth pipeline.

Chimeric Therapeutics has received a $4.5 million R&D tax incentive refund from the Australian Government, underscoring its ongoing investment in innovative cancer cell therapies.

Brightstar Resources outlines a bold growth strategy targeting over 200,000 ounces of annual gold production by 2029, leveraging its Western Australian assets and aggressive drilling programs. The company’s recent feasibility studies and acquisitions position it as a rising gold producer in the region.